Atul Mukund Deshpande
Geen lopende functies
Profiel
Atul Mukund Deshpande worked as an Associate Director at Sanofi, Inc. (China) from 2012 to 2014 and as an Executive Director & Chief Strategy Officer at HBM Holdings Ltd.
from 2018 to 2021.
He earned a doctorate degree from the University of California, Irvine in 2007, an MBA from Cranfield University in 2011, and an undergraduate degree from the University of Mumbai in 2000.
Eerdere bekende functies van Atul Mukund Deshpande
| Bedrijven | Functie | Einde |
|---|---|---|
| HBM HOLDINGS LIMITED | Directeur/Bestuurslid | 25-04-2021 |
Sanofi, Inc. (China)
 Sanofi, Inc. (China) Pharmaceuticals: MajorHealth Technology Part of Sanofi, Inc. (China) is a Chinese company that manufactures pharmaceutical products for heart, kidney, and diabetes problems. The company is based in Shanghai, China. | Corporate Officer/Principal | 01-12-2014 |
Opleiding van Atul Mukund Deshpande
| University of Mumbai | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
| Cranfield University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HBM HOLDINGS LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Sanofi, Inc. (China)
Sanofi, Inc. (China) Pharmaceuticals: MajorHealth Technology Part of Sanofi, Inc. (China) is a Chinese company that manufactures pharmaceutical products for heart, kidney, and diabetes problems. The company is based in Shanghai, China. | Health Technology |
